E-Medscribe Transcription Service is categorized under Services (Unclassified) in Houston, TX and active since 2010.
E-Medscribe Transcription Service was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.
If you are seeking more information, feel free to contact Marilyn Reynolds at the company’s single location by writing to 17303 Amber Creek Court, Houston, Texas TX 77095 or by phoning (281) 463-0531. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | E-Medscribe Transcription Service |
| Contact Person: | Marilyn Reynolds |
| Address: | 17303 Amber Creek Court, Houston, Texas 77095 |
| Phone Number: | (281) 463-0531 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Services (Unclassified) |
| SIC Code: | 8999 |
| NAICS Code: | 541990 |
| Share This Business: |
E-Medscribe Transcription Service was started in 2010 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Marilyn Reynolds for inquiries that concern E-Medscribe Transcription Service by calling the company number (281) 463-0531, as your correspondence is most welcome. Additionally, the physical location of the single location of E-Medscribe Transcription Service can be found at the coordinates 29.88955,-95.672707 as well as the street address 17303 Amber Creek Court in Houston, Texas 77095.
For its online presence, you may visit E-Medscribe Transcription Service’s website at and engage with its social media outlets through on Twitter and on Facebook.